M3, Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2019
January 25, 2019 at 11:30 am IST
Share
M3, Inc. announced consolidated earnings results for the nine months ended December 31, 2018. For the period, the company reported Net Sales were ¥83,674 million against ¥68,560 million a year ago. Operating profit was ¥22,958 million against ¥20,592 million a year ago. Net profit was ¥15,976 million against ¥14,281 million a year ago. Basic earnings per share were ¥22.5 against ¥20.67 a year ago. Diluted earnings per share were ¥22.49 against ¥20.66 a year ago.
For the year ending March 31, 2019, the company expects net sales of ¥113,350 million, operating profit of ¥31,720 million and net profit of ¥22,220 million or basic earnings per share of ¥32.36.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2019
M3, INC. 
